The drug parthenolide has IKB-Iκκ inhibitory activity and is able to induce apoptosis in AML cells coincident with NF-κB inhibition, p53 activation, and induction of reactive oxygen species (Neelakantan et al., 2009). The gene discussed is NFKB1; the disease is acute myeloid leukemia.